Dietary Acrylamide and Cancer Risk: Additional Data on Coffee
Author Information
Author(s): Mucci L A, Dickman P W, Steineck G, Adami H O, Augustsson K
Primary Institution: Karolinska Institutet
Hypothesis
Does dietary acrylamide contribute to cancer risk?
Conclusion
There is no evidence that dietary acrylamide is responsible for a major fraction of colorectal, bladder, or kidney cancers.
Supporting Evidence
- Acrylamide has been detected in coffee, which is commonly consumed.
- The daily mean dietary acrylamide dose increased with coffee data included.
- Coffee and crisp breads were major sources of dietary acrylamide among controls.
- The risk of colorectal and kidney cancers decreased with increasing acrylamide dose.
- The relative risk estimate of acrylamide and bladder cancer was essentially null.
Takeaway
Eating foods with acrylamide, like coffee, doesn't seem to cause cancer in people.
Methodology
The study used a case-control design to assess dietary acrylamide intake and cancer risk.
Potential Biases
The reliance on animal models for human cancer risk estimates may introduce bias.
Limitations
The study design has potential limitations, and additional data are needed for a global assessment.
Participant Demographics
The study population included Swedish individuals with varying coffee consumption habits.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website